On January 30 and February 5, 2014, European Union published the committee regulations of No 79/2014 and (EU) No 87/2014 respectively, amending the maximum residual limits of regulation annex II, III and V listed in (EC) No 396/2005, including bifenazate, chlorpropham, esfenvalerat, fludioxoni, thiobencarb, acetamiprid, butralin, chlorotoluron, daminozide, isoproturon, picoxystrobin, pyrimethanil and trinexapac

    (EU) No 79/2014 regulation takes effective since the 20^th after its publication, and it would be implemented from August 19, 2014.

    (EU) No 87/2014 regulation takes effective since the 20^th after its publication, and it would be implemented from August 25, 2014.

See whole text in link:

 Commission Regulation （EU） No 79/2014 of 29 January 2014 amending Annexes II, III and V to Regulation （EC） No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, chlorpropham, esfenvalerate, fludioxonil and thiobencarb in or on certain products <http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2014:027:0009:0055:EN:PDF>

Commission Regulation （EU） No 87/2014 of 31 January 2014 amending Annexes II, III and V to Regulation （EC） No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, butralin, chlorotoluron, daminozide, isoproturon, picoxystrobin, pyrimethanil and trinexapac in or on certain products

<http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2014:035:0001:0048:EN:PDF>